A detailed history of Napatree Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Napatree Capital LLC holds 4,568 shares of JNJ stock, worth $708,816. This represents 0.52% of its overall portfolio holdings.

Number of Shares
4,568
Previous 3,656 24.95%
Holding current value
$708,816
Previous $534 Million 38.54%
% of portfolio
0.52%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $132,677 - $152,650
912 Added 24.95%
4,568 $740 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $180,330 - $197,067
1,249 Added 51.89%
3,656 $534 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $13,038 - $13,670
84 Added 3.62%
2,407 $348 Million
Q4 2023

Mar 26, 2024

BUY
$145.6 - $158.88 $338,228 - $369,078
2,323 New
2,323 $364 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.